|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
2905446 |
| 003 |
ICU |
| 005 |
20030525204900.0 |
| 008 |
971014s1997 nyu b 101 0 eng c |
| 010 |
|
|
|a 97042392
|
| 020 |
|
|
|a 3805566026 (hardcover)
|
| 035 |
|
|
|a (OCoLC)37844445
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d NLM
|d OrLoB-B
|d OCoLC
|
| 049 |
|
|
|a CGUA
|
| 050 |
0 |
0 |
|a RC136.8
|b .I58 1998
|
| 060 |
1 |
0 |
|a W1
|b MO569P v.21 1998
|
| 060 |
1 |
0 |
|a WC 500
|b I6453c 1998
|
| 069 |
0 |
|
|a 9716238
|
| 082 |
0 |
0 |
|a 616.9/25
|2 21
|
| 111 |
2 |
|
|a International Consensus Round Table Meeting on CMV-Related Immunopatholoy
|n (1st :
|d 1997 :
|c Frankfurt am Main, Germany)
|
| 245 |
1 |
0 |
|a CMV-related immunopathology /
|c 1st International Consensus Round Table Meeting on CMV-Related Immunopatholoy, Frankfurt am Main, Germany, August 28-30, 1997 ; volume editors, Martin Scholz ... [et al.].
|
| 260 |
|
|
|a New York ;
|a Basel :
|b Karger,
|c 1998.
|
| 263 |
|
|
|a 9712
|
| 300 |
|
|
|a xii, 308 p.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Monographs in virology.
|v vol. 21
|
| 504 |
|
|
|a Includes bibliographical references and indexes.
|
| 505 |
0 |
0 |
|t Cytomegalovirus Persistence: Escape from Cell-Mediated Immunosurveillance /
|r D. M. Miller and D. D. Sedmak --
|t Mechanisms of Immunosuppression by Human Cytomegalovirus /
|r S. Michelson --
|t Human Cytomegalovirus Infection in Transplant Recipients: Role of TNF-[alpha] for Reactivation and Replication of Human Cytomegalovirus /
|r S. Prosch, H.-D. Volk and P. Reinke [et. al.] --
|t Pathogenesis of Murine Cytomegalovirus Infection in Neonatal Mice /
|r J. Trgovcich, E. Pernjak-Pugel and J. (Rijeka) Tomac [et. al.] --
|t Cytomegalovirus as a Perturbing Factor in a Graft/Host Equilibrium: Havoc at the Endothelial Interface /
|r W. J. Waldman --
|t Current Antiviral Therapy Fails to Prevent the Pro-Inflammatory Effects of Cytomegalovirus Infection, Whilst Rendering Infected Cells Relatively Resistant to Immune Attack /
|r J. E. Grundy --
|t Cytomegalovirus, Oxidative Stress and Inflammation as Interdependent Pathomechanisms: Need for Novel Therapeutic Strategies? /
|r M. Scholz, J.-U. Vogel and R. A. Blaheta [et. al.] --
|t Cytomegalovirus Infection following Hematopoietic Stem Cell Transplantation /
|r H. Einsele, H. Hebart and C. Bokemeyer [et. al.] --
|t Cytomegalovirus Pathogenesis after Experimental Bone Marrow Transplantation /
|r J. Podlech, H.-P. Steffens and R. Holtappels [et. al.] --
|t Two Types of Cytomegalovirus-Specific Memory Responses: Potential Role of Donor Infected Target Cells in Recruitment of Activated T Cells to the Graft /
|r A. Zeevi, K. Spichty and R. Banas [et. al.] --
|t Role of Cytomegalovirus Infection in the Processes of Organ Allograft Rejection /
|r I. Lautenschlager --
|t Role of Cytomegalovirus Infection in Transplant Arteriosclerosis /
|r C. A. Bruggeman and J. G. van Dam --
|t CMV Retinitis: Clinical Experience with the Metal Chelator Desferrioxamine /
|r H. Gumbel, J. Cinatl, Jr. and J.-U. Vogel [et. al.] --
|t Drug Resistance and the UL97 Gene of Human Cytomegalovirus /
|r A. Zimmerman, D. Michel and T. Mertens --
|t Antiviral Agents That Are Active against CMV: Potential of Cidofovir for the Treatment of CMV and Other Virus Infections /
|r E. De Clercq --
|t Cidofovir, a New Addition to the Available Therapies against Cytomegalovirus /
|r W. De Cian --
|t New Anti-CMV Strategies /
|r C. Mocklinghoff --
|t Immunomodulation with Intravenous Immunoglobulins in the Treatment of Cytomegalovirus-Associated Immunopathology and Autoimmune Diseases /
|r S. Kaveri --
|t Analytical Performance of a Quantitative CMV DNA Detection Method /
|r K. J. Reagan, C. Cabradilla and B. Shuman [et. al.] --
|t Relationship between Monitoring the Viral Load in Blood, Human Cytomegalovirus Pathophysiology and Management Strategies of Patients after Transplantation /
|r T. H. The, M. C. Harmsen and W. van der Bij [et. al.] --
|t Quantitative Cytomegalovirus Detection /
|r R. Kaiser, J. K. Rockstroh and A. M. Eis-Hubinger [et. al.] --
|t Relative Importance of Cytomegalovirus Load as a Risk Factor for Cytomegalovirus Disease in the Immunocompromised Host /
|r V. C. Emery.
|
| 650 |
|
0 |
|a Cytomegalovirus infections
|x Immunological aspects
|v Congresses.
|
| 650 |
|
0 |
|a Immunosuppression
|v Congresses.
|
| 650 |
|
0 |
|a Transplantation of organs, tissues, etc.
|x Complications
|v Congresses.
|
| 650 |
|
0 |
|a AIDS (Disease)
|x Complications
|v Congresses.
|
| 650 |
1 |
2 |
|a Cytomegalovirus Infections
|x physiopathology
|v congresses.
|
| 650 |
2 |
2 |
|a Cytomegalovirus Infections
|x therapy
|v congresses.
|
| 650 |
2 |
2 |
|a Cytomegalovirus Infections
|x diagnosis
|v congresses.
|
| 650 |
1 |
2 |
|a Cytomegalovirus
|x immunology
|v congresses.
|
| 650 |
2 |
2 |
|a Immunocompromised Host
|x immunology
|v congresses.
|
| 650 |
|
7 |
|a AIDS (Disease)
|x Complications.
|2 fast
|0 http://id.worldcat.org/fast/fst00793817
|
| 650 |
|
7 |
|a Immunosuppression.
|2 fast
|0 http://id.worldcat.org/fast/fst00968033
|
| 650 |
|
7 |
|a Transplantation of organs, tissues, etc.
|x Complications.
|2 fast
|0 http://id.worldcat.org/fast/fst01154921
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
| 700 |
1 |
|
|a Scholz, Martin,
|d 1960-
|0 http://id.loc.gov/authorities/names/n97803317
|1 http://viaf.org/viaf/73149486
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 518f1080-c4e5-5fd2-90ea-e61bd92071d3
|s c757844d-6744-5610-9bdf-b627a7dc8305
|
| 928 |
|
|
|t Library of Congress classification
|a RC136.8.I58 1998
|l ASR
|c ASR-SciASR
|i 3255727
|
| 927 |
|
|
|t Library of Congress classification
|a RC136.8.I58 1998
|l ASR
|c ASR-SciASR
|e CRERAR
|b 45390383
|i 5182203
|
